"The National Institutes of Health is expanding their role in translational research and the treatment development process with the announced creation of the National Center for Advancing Translational Sciences. The mission behind the new agency is to target public sector research that will facilitate private industry interest and investment."
As reported from the Leukemia and Lymphoma Society